Announcements Trials
Browse Landscape

Status

Recruiting 2Completed 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Postoperative Complications 1Ovarian Neoplasms 1Multiple Myeloma 1Carcinoma, Ovarian Epithelial 1

Interventions

Carboplatin 44Paclitaxel 43liposomal doxorubicin 23Topotecan 19Gemcitabine 18pembrolizumab 17Cyclophosphamide 17Bevacizumab 16Cisplatin 12niraparib 9olaparib 8fludarabine 7Taxes 7Docetaxel 7aldesleukin 6Nivolumab 6Doxorubicin 61-dodecylpyridoxal 6oregovomab 5fludarabine phosphate 5Peripheral Blood Stem Cell Transplantation 5Filgrastim 5rucaparib 4durvalumab 4avelumab 4Surgical Procedures, Operative 4Melphalan 4Ipilimumab 4Interleukin-2 4Etoposide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Ovarian Neoplasms × Geriatric Assessment × Clear all
NCT01175967 2015-10-12

Use of Palliative Performance and Symptom Distress Scales in Older Patients With Advanced Ovarian Cancer

UNC Lineberger Comprehensive Cancer Center

Terminated
11 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡